Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes.

Abstract After intraperitoneal injections of 3 H-spiperone into the rat, brain membrane preparations retain the majority of the radioactivity even after several buffer washes. With 3 H-spiperone as ligand, dissociation constants were significantly elevated and maximum binding unchanged in rat striatal membranes after acute intraperitoneal injection of chlorpromazine (14 mg/kg). It is suggested that in studies of post-mortem brains of schizophrenics that contain neuroleptics specific 3 H-spiperone binding will be lowered by competition from residual drug in membrane preparations and valid comparisons of 3 H-spiperone binding to preparations from control and schizophrenic brains can only be made if maximum binding values are determined.

[1]  P. Seeman,et al.  Enhanced binding of chlorpromazine to cholesterol-depleted synaptosome fractions. , 1974, Canadian journal of physiology and pharmacology.

[2]  P. Seeman,et al.  The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. , 1974, The Journal of pharmacology and experimental therapeutics.

[3]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[4]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[5]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[6]  S. Hess,et al.  THE DISTRIBUTION AND METABOLISM OF FLUPHENAZINE ENANTHATE. , 1965, The Journal of pharmacology and experimental therapeutics.

[7]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[8]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[9]  M. Poulter,et al.  INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA , 1978, The Lancet.

[10]  C. Cori,et al.  Purification of the hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa. , 1949, The Journal of biological chemistry.

[11]  L. Iversen,et al.  3H-Spiperone binding in normal and schizophrenic post-mortem human brain. , 1978, Life sciences.